Document is current

Any future updates will be listed below

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Crossref DOI link: https://doi.org/10.21037/tlcr-20-359

Published Online: 2021-01

Published Print: 2021-01

Update policy: https://doi.org/10.21037/ame_crossmark_policy

About CrossMark